Compounds > cabergoline
Page last updated: 2024-08-23

cabergoline and Gigantism

cabergoline has been researched along with Gigantism in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albrecht, S; Barry, S; Bunce, B; Caswell, R; Ellard, S; Evanson, J; Iacovazzo, D; Jose, S; Korbonits, M; Millette, M; Rodd, C; Roncaroli, F; Sampson, J; Stiles, CE; Trouillas, J1
Ali, O; Banerjee, S; Kelly, DF; Lee, PD1
Fujieda, K; Ishi, N; Ishizu, K; Jo, W; Tajima, T; Tsubaki, J1
Herman-Bonert, V; Kovacs, K; Maheshwari, HG; Melmed, S; Prezant, TR; Shahinian, H1

Other Studies

4 other study(ies) available for cabergoline and Gigantism

ArticleYear
Somatic GPR101 Duplication Causing X-Linked Acrogigantism (XLAG)-Diagnosis and Management.
    The Journal of clinical endocrinology and metabolism, 2016, Volume: 101, Issue:5

    Topics: Cabergoline; Child, Preschool; Ergolines; Gene Duplication; Gigantism; Human Growth Hormone; Humans; Male; Pituitary Gland; Receptors, G-Protein-Coupled

2016
Management of type 2 diabetes mellitus associated with pituitary gigantism.
    Pituitary, 2007, Volume: 10, Issue:4

    Topics: Adenoma; Adolescent; Antineoplastic Agents; Cabergoline; Combined Modality Therapy; Diabetes Mellitus, Type 2; Ergolines; Gigantism; Human Growth Hormone; Humans; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Long-Acting; Male; Metformin; Pituitary Neoplasms; Radiotherapy

2007
Case study of a 15-year-old boy with McCune-Albright syndrome combined with pituitary gigantism: effect of octreotide-long acting release (LAR) and cabergoline therapy.
    Endocrine journal, 2008, Volume: 55, Issue:3

    Topics: Adolescent; Antineoplastic Agents; Cabergoline; Delayed-Action Preparations; Ergolines; Fibrous Dysplasia, Polyostotic; Gigantism; Humans; Male; Octreotide; Radiography

2008
Long-acting peptidomimergic control of gigantism caused by pituitary acidophilic stem cell adenoma.
    The Journal of clinical endocrinology and metabolism, 2000, Volume: 85, Issue:9

    Topics: Adenoma, Acidophil; Adolescent; Antineoplastic Agents, Hormonal; Cabergoline; Delayed-Action Preparations; Dopamine Agonists; Ergolines; Female; Gigantism; Hormones; Humans; Magnetic Resonance Imaging; Octreotide; Pituitary Neoplasms; Receptors, Dopamine D2; Receptors, Somatostatin; Reverse Transcriptase Polymerase Chain Reaction; Stem Cells

2000